Reduced expression of PTEN correlates with breast cancer progression

This publication has 16 references indexed in Scilit:

• An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity inPten^+/−mice
  Proceedings of the National Academy of Sciences, 2001
• No evidence for germlinePTEN mutations in families with breast and brain tumours
  International Journal of Cancer, 1999
• Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas
  British Journal of Cancer, 1999
• Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer
  Oncogene, 1998
• Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas
  Oncogene, 1998
• Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
  Human Molecular Genetics, 1998
• Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus
  Genes, Chromosomes and Cancer, 1998
• Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
  Nature Genetics, 1997
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
  Nature Genetics, 1997
• PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
  Science, 1997